Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Why you should care about translational research

Harry Shamoon, MD
Education
April 7, 2014
Share
Tweet
Share

Translational research is a catchphrase in biomedical circles these days. But if you’re confused about what the term really means, you’re not alone.

It was 35 years ago when I first heard the term “translation” in a scientific context. It was about enabling basic research undertaken by the National Institutes of Health (NIH) to find its way into treatments for patients. Though that sounds pretty straightforward, I still have to explain it not only to the lay public but even to my colleagues. Why? One reason may be that translational research no longer just describes a process, but characterizes an entirely new discipline.

A lot has happened since the 1980s, including the creation in 2012 of a new NIH institute — the National Center for Advancing Translational Sciences. This is one of the only NIH centers that is not disease-focused (unlike, for example, the National Cancer Institute or the National Institute of Mental Health). Its director, Dr. Christopher Austin, spoke at Einstein last fall and described NCATS’s mission: to “catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of interventions that tangibly improve human health across a wide range of human diseases and conditions”

What have you done for me lately?

You might say, “Okay, that’s all well and good, but why should I care about translational research?” One answer is that industry, scientists and research agencies have all noted the alarming lack of innovative treatments being approved over the past several years despite strong overall research funding. Data suggest that the explosion in translational research in the past decade has caused it to outstrip its NIH funding. (See a recent paper by Dr. Lloyd Fricker.) This implies that the real problem may be a breakdown in the long road from the science lab to the prescription pad.

“Translational research” can most simply be defined as investigation that is informed and framed by a robust understanding of human biology and disease. This all-encompassing approach thus bridges the spectrum from basic research to health outcomes. However, the terminology can be somewhat confusing because there are many types of translational science disciplines. One way to say it is that multiple translational sciences link together to make translational research happen. 

Science silos

Translational research involves teams of investigators who have different areas of expertise. Our biomedical disciplines, such as “pharmacology,” “cardiology,” “cell biology,” “epidemiology” and “genetics,” can create artificial boundaries that are difficult to overcome. (See A. Casadevall and F. C. Fang, “Specialized Science,” Infection and Immunity, 2014.) These days, every scientist has become a superspecialist and may have trouble communicating, even with those in adjacent disciplines.

Translational research requires a special breed who are eager to work with and integrate disparate fields. In translational research, genetics may be as important as informatics for an epidemiologist, and “big data” are as vital for understanding a biological pathway as computer models are for health outcomes.

Valleys of death

Translational research also brings us face to face with “valleys of death” that can hinder research as it advances through phases labeled T0→T1→T2→T3→T4. In this shorthand, T0 is basic scientific discovery; T1 tests discoveries in model animal systems; T2 spans the translation of knowledge from the lab into treatments for people; T3, or efficacy research, applies new interventions to larger patient populations; and T4, or effectiveness research, evaluates the methods used to affect healthcare for patients in real-life, community settings.

At the end of the day, what links all translational researchers regardless of their specific disciplines is their ability to foresee these gaps, and to think creatively about how to bridge them.

Engineering solutions

Translational research is at a crossroads. While research funding is threatened by many of today’s societal and economic challenges, the research community must also take responsibility for its own shortcomings. The best way to advance translational research would be to better understand and address the gaps among disciplines, since that’s where teams of scientists will — as Tom Friedman would say — invent the future.

Harry Shamoon is associate dean, clinical and translational research, Albert Einstein College of Medicine, Bronx, NY. He blogs at The Doctor’s Tablet.

Prev

Why this cardiologist mourns the death of the stethoscope

April 7, 2014 Kevin 4
…
Next

When pediatricians write prescriptions for off-label use

April 7, 2014 Kevin 1
…

ADVERTISEMENT

Post navigation

< Previous Post
Why this cardiologist mourns the death of the stethoscope
Next Post >
When pediatricians write prescriptions for off-label use

ADVERTISEMENT

Related Posts

  • How social media can help or hurt your health care career

    Health eCareers
  • Medical trainees need knowledge and education on health care systems and policy

    Daniel Arteaga, MD, MBA and Isobel Rosenthal, MD, MBA
  • The role of medical education in perpetuating health care disparities

    Anonymous
  • The rural health care crisis and medical education

    Nick Richwagen, Evan Chen, and Jacob Riegler
  • What makes health care workers superhuman

    Eric Tian
  • Why medical students need more continuity of care training

    Nathaniel Fleming

More in Education

  • Learning medicine in the age of AI: Why future doctors need digital fluency

    Kelly D. França
  • Why health care must adopt a harm reduction model

    Dylan Angle
  • Gen Z’s DIY approach to health care

    Amanda Heidemann, MD
  • What street medicine taught me about healing

    Alina Kang
  • How listening makes you a better doctor before your first prescription

    Kelly Dórea França
  • What it means to be a woman in medicine today

    Annie M. Trumbull
  • Most Popular

  • Past Week

    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • Federal shakeup of vaccine policy and the battle for public trust [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Federal shakeup of vaccine policy and the battle for public trust [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Why clinicians must lead health care tech innovation

      Kimberly Smith, RN | Tech
    • The truth about sun exposure: What dermatologists want you to know

      Shafat Hassan, MD, PhD, MPH | Conditions
    • Learning medicine in the age of AI: Why future doctors need digital fluency

      Kelly D. França | Education
    • How a South Asian nurse challenged stereotypes in health care

      Viksit Bali, RN | Conditions
    • Doctors reclaiming their humanity in a broken system [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why primary care needs better dermatology training

      Alex Siauw | Conditions
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
    • Federal shakeup of vaccine policy and the battle for public trust [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Federal shakeup of vaccine policy and the battle for public trust [PODCAST]

      American College of Physicians & The Podcast by KevinMD | Podcast
    • Why clinicians must lead health care tech innovation

      Kimberly Smith, RN | Tech
    • The truth about sun exposure: What dermatologists want you to know

      Shafat Hassan, MD, PhD, MPH | Conditions
    • Learning medicine in the age of AI: Why future doctors need digital fluency

      Kelly D. França | Education
    • How a South Asian nurse challenged stereotypes in health care

      Viksit Bali, RN | Conditions
    • Doctors reclaiming their humanity in a broken system [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...